Home › Marginal Zone Lymphoma › Missouri
Marginal Zone Lymphoma clinical trials in Missouri
6 studies for Marginal Zone Lymphoma are looking for participants at sites in Missouri.
Cities in Missouri
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Saint Francis Medical Center, Cape Girardeau
- Heartland Regional Medical Center, Saint Joseph
- Mercy Hospital South, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04840602This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT0712194664Cu-LLP2A for Imaging Hematologic Malignancies
- Washington University School of Medicine, St Louis
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06636175Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
- Washington University, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06390956A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Washington University, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 14, 2025 · NCT05643742SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.